Capricor Therapeutics | CAPR - Cash And Equivalent


Capricor Therapeutics reported $287.85M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Bioline Rx USD 7.91M 725K Sep/2025
Capricor Therapeutics USD 287.85M 268.34M Dec/2025
Cipla INR 7.96B 39.9M Sep/2025
Cytokinetics USD 129.84M 7.32M Mar/2026
Geron USD 79.44M 553K Dec/2025
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 15.48M 19.65M Dec/2025
J&J USD 21.69B 1.98B Mar/2026
Plus Therapeutics USD 4.26M 9.03M Dec/2025
Prothena USD 307.53M 23.31M Dec/2025
PTC Therapeutics USD 984.65M 312.03M Dec/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025